European healthtech investment in H1 2026 was driven bylarge funding rounds, with continued interest in biotechnology, medical devicesand AI-powered healthcare solutions.The UK attracted significant i…
This is a summary
The full article is published by Tech.eu. We hold only a headline and a short summary here.
Read the full article